The Prognostic Value of Human Papilloma Virus in Nasopharyngeal Carcinoma
Overview
It is well established that HPV infection has a casual and is a prognostic factor in several cancer types, including oropharynx. We wish to examine if HPV infection has a prognostic significance in nasopharyngeal carcinoma.
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Retrospective
- Study Primary Completion Date: July 2020
Clinical Trial Outcome Measures
Primary Measures
- Overall survival
- Time Frame: 6 months
Participating in This Clinical Trial
Inclusion Criteria
- nasopharyngeal carcinoma patients treated in our institute between 2008-2018 Exclusion Criteria:
- missing clinical data – 2nd Head and neck primary cancer – very locally advanced or distant metastatic nasopharyngeal carcinoma – Prior radiation therapy to the head and neck region
Gender Eligibility: All
Minimum Age: N/A
Maximum Age: N/A
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Rambam Health Care Campus
- Provider of Information About this Clinical Study
- Sponsor
- Overall Official(s)
- Eran S Fridman, MD, Principal Investigator, Rambam Health Care Campus
- Overall Contact(s)
- Eran S Fridman, MD, +972-4-7772480, eran.frid@gmail.com
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.